Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biora Therapeutics Inc (BIOR)

Biora Therapeutics Inc (BIOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 995
  • Shares Outstanding, K 4,523
  • Annual Sales, $ 4 K
  • Annual Income, $ -124,120 K
  • EBIT $ -61 M
  • EBITDA $ -59 M
  • 60-Month Beta 1.12
  • Price/Sales 497.61
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -21.98
  • Most Recent Earnings $-6.08 on 11/14/24
  • Next Earnings Date 03/25/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -3.30
  • Number of Estimates 2
  • High Estimate -3.10
  • Low Estimate -3.50
  • Prior Year -6.30
  • Growth Rate Est. (year over year) +47.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1500 +46.67%
on 12/30/24
2.1058 -89.55%
on 12/02/24
-1.7300 (-88.72%)
since 11/29/24
3-Month
0.1500 +46.67%
on 12/30/24
5.9700 -96.31%
on 10/16/24
-4.7960 (-95.61%)
since 09/30/24
52-Week
0.1500 +46.67%
on 12/30/24
19.9000 -98.89%
on 02/28/24
-13.2800 (-98.37%)
since 12/29/23

Most Recent Stories

More News
Biora Therapeutics Successfully Completes Restructuring Process

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

BIOR : 0.2200 (-50.01%)
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Shares Progress on Smaller BioJetâ„¢ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting

BIOR : 0.2200 (-50.01%)
Biora Therapeutics to Reveal 00-Size BioJetâ„¢ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting

BIOR : 0.2200 (-50.01%)
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Announces Successful Completion of Device Performance Study in Ulcerative Colitis Patients for its Targeted Therapeutics Platform

All Devices Successfully Detected Colon Entry in Patients with Active Ulcerative Colitis...

BIOR : 0.2200 (-50.01%)
Biora Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update

SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today...

BIOR : 0.2200 (-50.01%)

Business Summary

Biora Therapeutics Inc. is a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond. Biora Therapeutics Inc., formerly known as Progenity Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 0.5803
2nd Resistance Point 0.4803
1st Resistance Point 0.3501
Last Price 0.2200
1st Support Level 0.1199
2nd Support Level 0.0199
3rd Support Level N/A

See More

52-Week High 19.9000
Fibonacci 61.8% 12.3555
Fibonacci 50% 10.0250
Fibonacci 38.2% 7.6945
Last Price 0.2200
52-Week Low 0.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar